CHAIN Biotech Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
9
- Latest Deal Type
-
Liquidation
CHAIN Biotech General Information
Description
Developer of a proprietary microbial platform designed to help in drug delivery. The company's platform involves the development and use of engineered clostridia to deliver specific therapeutics to the gut and supports a product pipeline for a wide range of clinical indications, including localized infections, inflammation, and central nervous system signaling, enabling patients to get an engineered strain that secretes a novel and potent anti-inflammatory molecule targeting inflammatory bowel disease and chronic gut disease.
Contact Information
Website
www.chainbiotech.comCorporate Office
- Level 1 Bessemer Building
- Imperial College London
- London SW7 2AZ
- England, United Kingdom
Corporate Office
- Level 1 Bessemer Building
- Imperial College London
- London SW7 2AZ
- England, United Kingdom
CHAIN Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Bankruptcy: Liquidation | 23-Jul-2026 | Completed | Bankruptcy: Liquidation | |||
| 8. Seed Round | 09-Jun-2023 | Completed | Generating Revenue | |||
| 7. Seed Round | 10-Sep-2021 | Completed | Pre-Clinical Trials | |||
| 6. Seed Round | 01-Nov-2018 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 12-Sep-2017 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 03-Apr-2017 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 2. Seed Round | 23-Dec-2015 | $199K | $199K | Completed | Pre-Clinical Trials | |
| 1. Grant | 16-Oct-2015 | $299K | Completed | Pre-Clinical Trials |
CHAIN Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 154,451 | $0.001244 | $5.19 | $5.19 | 1x | $5.19 | 9.06% | |
| Ordinary | 51,800 | $0.001244 | $3.17 | $3.17 | 1x | $3.17 | 3.04% |
CHAIN Biotech Comparisons
Industry
Financing
Details
CHAIN Biotech Competitors (18)
One of CHAIN Biotech’s 18 competitors is Bloom Science, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bloom Science | Venture Capital-Backed | San Diego, CA | ||||
| Thabor Therapeutics | Venture Capital-Backed | Paris, France | ||||
| EverImmune | Venture Capital-Backed | Villejuif, France | ||||
| Nextera | Venture Capital-Backed | Oslo, Norway | ||||
| GlycosBio | Venture Capital-Backed | Houston, TX |
CHAIN Biotech Patents
CHAIN Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202209115-D0 | Compositions and methods | Inactive | 21-Jun-2022 | ||
| WO-2023247936-A1 | Compositions and methods | Inactive | 21-Jun-2022 | ||
| AU-2021404131-A1 | Compositions and methods | Pending | 15-Dec-2020 | ||
| CA-3202257-A1 | Compositions and methods | Pending | 15-Dec-2020 | ||
| EP-4262861-A1 | Compositions and methods | Pending | 15-Dec-2020 | A61K39/107 |
CHAIN Biotech Signals
CHAIN Biotech FAQs
-
When was CHAIN Biotech founded?
CHAIN Biotech was founded in 2014.
-
Where is CHAIN Biotech headquartered?
CHAIN Biotech is headquartered in London, United Kingdom.
-
What is the size of CHAIN Biotech?
CHAIN Biotech has 9 total employees.
-
What industry is CHAIN Biotech in?
CHAIN Biotech’s primary industry is Drug Delivery.
-
Is CHAIN Biotech a private or public company?
CHAIN Biotech is a Private company.
-
What is CHAIN Biotech’s current revenue?
The current revenue for CHAIN Biotech is .
-
How much funding has CHAIN Biotech raised over time?
CHAIN Biotech has raised $5.29M.
-
Who are CHAIN Biotech’s competitors?
Bloom Science, Thabor Therapeutics, EverImmune, Nextera, and GlycosBio are some of the 18 competitors of CHAIN Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process